+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Regenerative Medicine Market - Growth, Trends, and Forecast (2020 - 2025)

  • ID: 4745455
  • Report
  • May 2020
  • Region: Global
  • 110 pages
  • Mordor Intelligence
UP TO OFF
until Jun 30th 2020
1 of 4

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • Allergan Plc
  • Baxter
  • Cook Biotech Incorporated
  • Integra Lifesciences
  • Medtronic Plc
  • Organogenesis Inc.
  • MORE
The key factors propelling the growth of the global regenerative medicine market are the increasing adoption of stem cell technologies, gene therapies, and tissue engineering, and the technological advancements in regenerative medicine.

Stem cell technology is a rapidly developing technology that plays a major role in regenerative medicine, as it also serves the disciplines of tissue engineering, developmental cell biology, cellular therapeutics, gene therapy, chemical biology, and nanotechnology. Stem cells offer the possibility of replacing the cells and tissues to treat various conditions including spinal cord injury, arthritis, and Parkinson’s disease, among others. The applications of stem cell technologies in the treatment of diseases have ultimately increased the overall adoption rate of these technologies across the world.

The market is found experiencing the major technological advancements in biologics, biomaterials, stem cell technology, and tissue engineering, thus contributing to the market growth. There are also various recent advancements in regenerative medicine, including the regenerated tracheas for transplant, 3D bioprinting, stem cell treatments for vision loss, and stem cell treatments for heart repair.

The current market is also witnessing extensive R&D activities. Apart from the R&D activities being conducted by private players, there is significant involvement of academic institutions for conducting various research. Therefore, in the future, several new biotech and medtech companies are expected to come up, as the result of the current R&D endeavors across the world.

Key Market Trends

Dermatology is the Segment by Application that is Expected to be the Largest During the Forecast Period

Dermatology is estimated to have the largest share in revenue generation, and this high contribution is attributive to the presence of easy grafting techniques for dermatological wounds and diseases. Skin, being an organ with great cell replication characteristics, provides various types of stem cells from its different layers. Therefore, there is a broad range of products present, from patches to cure small injuries to matrix and grafts for chronic wounds and burns. Thus, the segment is expected to continue to dominate the market through the forecast period.

The increasing number of accidents and bone defects is also expected to drive the regenerative medicine market. There are also several research studies that are being conducted on tissue engineering for the development of bone graft substitutes, with the help of regenerative medicine. So, with the new advances in bone graft, the market is expected to grow over the forecast period.

North America Holds the Largest Share and is Expected to Follow the Same Trend Over the Forecast Period

North America is estimated to have the largest share, in terms of revenue, owing to the presence of major players and rapid advances in technology, along with high investments in stem cell and oncology research. There is also an increasing prevalence of diseases, such as cancer and diabetes, which can now be cured by various stem cell therapies. Additionally, the awareness regarding the available stem cell procedures and therapies among people is rising, which in turn, is increasing the demand for the overall market.

Competitive Landscape

The global regenerative medicine market is highly competitive. The small-scale companies are also merging with large companies to develop tissue models for research and therapeutic purposes. Thus, companies are making considerable investments in novel technologies, thus driving the market. Moreover In the coming years few other players are expected to enter into the market.

Reasons to Purchase this report:
  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Allergan Plc
  • Baxter
  • Cook Biotech Incorporated
  • Integra Lifesciences
  • Medtronic Plc
  • Organogenesis Inc.
  • MORE
1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Adoption of Stem Cell Technology
4.2.2 Technological Advancements in Regenerative Medicine
4.3 Market Restraints
4.3.1 Regulatory and Ethical Issues
4.3.2 High Cost of Treatments
4.4 Porter's Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION
5.1 By Type of Technology
5.1.1 Stem Cell Therapy
5.1.2 Biomaterial
5.1.3 Tissue Engineering
5.1.4 Other Types of Technologies
5.2 By Application
5.2.1 Bone Graft Substitutes
5.2.2 Osteoarticular Diseases
5.2.3 Dermatology
5.2.4 Cardiovascular
5.2.5 Central Nervous System
5.2.6 Other Applications
5.3 Geography
5.3.1 North America
5.3.1.1 United States
5.3.1.2 Canada
5.3.1.3 Mexico
5.3.2 Europe
5.3.2.1 Germany
5.3.2.2 United Kingdom
5.3.2.3 France
5.3.2.4 Italy
5.3.2.5 Spain
5.3.2.6 Rest of Europe
5.3.3 Asia-Pacific
5.3.3.1 China
5.3.3.2 Japan
5.3.3.3 India
5.3.3.4 Australia
5.3.3.5 South Korea
5.3.3.6 Rest of Asia-Pacific
5.3.4 Middle East & Africa
5.3.4.1 GCC
5.3.4.2 South Africa
5.3.4.3 Rest of Middle East & Africa
5.3.5 South America
5.3.5.1 Brazil
5.3.5.2 Argentina
5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Allergan Plc
6.1.2 Osiris Therapeutics (Smith & Nephew)
6.1.3 Integra Lifesciences
6.1.4 Cook Biotech Incorporated
6.1.5 Organogenesis Inc.
6.1.6 Baxter
6.1.7 Medtronic Plc
6.1.8 Thermo Fisher Scientific
6.1.9 Sigma-Aldrich Co.
6.1.10 Becton Dickinson and Company

7 MARKET OPPORTUNITIES AND FUTURE TRENDS
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Allergan Plc
  • Osiris Therapeutics (Smith & Nephew)
  • Integra Lifesciences
  • Cook Biotech Incorporated
  • Organogenesis Inc.
  • Baxter
  • Medtronic Plc
  • Thermo Fisher Scientific
  • Sigma-Aldrich Co.
  • Becton Dickinson and Company
Note: Product cover images may vary from those shown
Adroll
adroll